by Luena | May 31, 2024 | Neuroana
Neurological conditions ranging from migraine to stroke, Parkinson’s disease and dementia, are now the leading cause of ill-health worldwide, causing 11.1 million deaths in 2021, research has revealed. The number of people living with or dying from disorders of the...
by Luena | May 31, 2024 | Neuroana
New data has recently been published providing compelling evidence that clinicians should consider repetitive transcranial magnetic stimulation (TMS) much earlier for patients who do not respond to antidepressant medication. The study focused on 278 individuals...
by Luena | May 31, 2024 | Neuroana
Neuronetics (Nasdaq:STIM) announced today that it received FDA clearance for the use of its NeuroStar therapy for adolescent patients. Clearance covers the use of NeuroStar as an adjunct treatment of major depressive disorder (MDD) in adolescent patients aged 15-21....
by Luena | May 31, 2024 | Neuroana
In the realm of EEG research, the journey from EEG data acquisition to insightful interpretation is guided by a suite of specialized software tools. These tools, each tailored to specific analytical goals, form a cohesive ecosystem that empowers researchers to unlock...
by Luena | May 31, 2024 | Neuroana
Researchers have developed a new method to calculate the difference between a person’s chronological age and brain age. This machine-learning model uses EMOTIV EPOC X headsets to measure the electrical activity during a brain’s resting state (awake but...
